Innovating Works
SC1-HCO-06-2016
SC1-HCO-06-2016: Towards an ERA-NET for building sustainable and resilient health system models
Specific Challenge:Currently, public health-related research, whether population health or health services research, is fragmented, not coordinated and not aligned across the European Union. There is a need to render investments in public health research more efficient, learn from each other and better capitalise on the on-going so called 'natural experiments' in Europe. While some public health problems are specific to countries, and health care systems are different. Member States still face many similar challenges. There are many public health problems common to most countries, such as the burden posed by chronic diseases, multi-morbidity or obesity, and mental health issues. Many countries are considering innovative solutions in order to achieve a better design of services and interventions throughout the entire chain of care, including public health and prevention. It implies, among others, strategies for strengthening community care and primary care in relation to social care and prevention, redesigning hospital care and de-institutionalising long term care with more care provided closer to home. This implies placing more emphasis on self-management of patients and new ways of linking health and social care. There are many opportunities to learn from one another on what works best under what conditions, agreeing on what issues could be best researched jointly, and where the problems are more localized. This is an opportunity of capitalizing on existing know-how and to draw on comparative advantages in European research, thus enhancing innovation.
Sólo fondo perdido 0 €
Europeo
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 13-04-2016.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio.
Número mínimo de participantes.
Esta ayuda financia Proyectos: Objetivo del proyecto:

Specific Challenge:Currently, public health-related research, whether population health or health services research, is fragmented, not coordinated and not aligned across the European Union. There is a need to render investments in public health research more efficient, learn from each other and better capitalise on the on-going so called 'natural experiments' in Europe. While some public health problems are specific to countries, and health care systems are different. Member States still face many similar challenges. There are many public health problems common to most countries, such as the burden posed by chronic diseases, multi-morbidity or obesity, and mental health issues. Many countries are considering innovative solutions in order to achieve a better design of services and interventions throughout the entire chain of care, including public health and prevention. It implies, among others, strategies for strengthening community care and primary care in relation to social care and prevention, redesigning hospital care and de-institutionalising long term care with more care provided closer to home. This implies placing more emphasis on self-management of patients and... ver más

Specific Challenge:Currently, public health-related research, whether population health or health services research, is fragmented, not coordinated and not aligned across the European Union. There is a need to render investments in public health research more efficient, learn from each other and better capitalise on the on-going so called 'natural experiments' in Europe. While some public health problems are specific to countries, and health care systems are different. Member States still face many similar challenges. There are many public health problems common to most countries, such as the burden posed by chronic diseases, multi-morbidity or obesity, and mental health issues. Many countries are considering innovative solutions in order to achieve a better design of services and interventions throughout the entire chain of care, including public health and prevention. It implies, among others, strategies for strengthening community care and primary care in relation to social care and prevention, redesigning hospital care and de-institutionalising long term care with more care provided closer to home. This implies placing more emphasis on self-management of patients and new ways of linking health and social care. There are many opportunities to learn from one another on what works best under what conditions, agreeing on what issues could be best researched jointly, and where the problems are more localized. This is an opportunity of capitalizing on existing know-how and to draw on comparative advantages in European research, thus enhancing innovation.


Scope:To pave the way to an ERA-NET co-fund action for building sustainable and resilient health systems models, this coordination and support action (CSA) will develop a structured system of exchange of information between public health research funders and other relevant bodies, as well as academia, in order to establish synergies and avoid duplication. It will further facilitate the development of a strategic research agenda taking into account the diversity which exists within Europe. This agenda will identify at least a number of measurable, performance enhancing, scientific-technological or socio-economic objectives, supported by an appropriate analysis.

This action implies the preparation and organisation of meetings as well as support to information exchange with relevant stakeholders groups and with the public at large.

The proposed action should ensure a broad geographical representation of European countries.

The Commission considers that proposals requesting a contribution from the EU of between EUR 1 and 2 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.


Expected Impact: Build on the communalities of existing knowledge gathering in past EU and national level studies, thus ensure a better use of limited resources. Identification of common research priorities and research needs, also taking into account developments at the international level where relevant. Development and alignment of national and regional plans. Sharing of data, metadata, knowledge and best practice.
Cross-cutting Priorities:GenderSocio-economic science and humanities


ver menos

Temáticas Obligatorias del proyecto: Temática principal: Cost efficiency Healthcare system Quality of health care Health care sciences and services (including hospi Public health policies

Características del consorcio

Ámbito Europeo : La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:

Características del Proyecto

Requisitos de diseño: Duración:
Requisitos técnicos: Specific Challenge:Currently, public health-related research, whether population health or health services research, is fragmented, not coordinated and not aligned across the European Union. There is a need to render investments in public health research more efficient, learn from each other and better capitalise on the on-going so called 'natural experiments' in Europe. While some public health problems are specific to countries, and health care systems are different. Member States still face many similar challenges. There are many public health problems common to most countries, such as the burden posed by chronic diseases, multi-morbidity or obesity, and mental health issues. Many countries are considering innovative solutions in order to achieve a better design of services and interventions throughout the entire chain of care, including public health and prevention. It implies, among others, strategies for strengthening community care and primary care in relation to social care and prevention, redesigning hospital care and de-institutionalising long term care with more care provided closer to home. This implies placing more emphasis on self-management of patients and new ways of linking health and social care. There are many opportunities to learn from one another on what works best under what conditions, agreeing on what issues could be best researched jointly, and where the problems are more localized. This is an opportunity of capitalizing on existing know-ho... Specific Challenge:Currently, public health-related research, whether population health or health services research, is fragmented, not coordinated and not aligned across the European Union. There is a need to render investments in public health research more efficient, learn from each other and better capitalise on the on-going so called 'natural experiments' in Europe. While some public health problems are specific to countries, and health care systems are different. Member States still face many similar challenges. There are many public health problems common to most countries, such as the burden posed by chronic diseases, multi-morbidity or obesity, and mental health issues. Many countries are considering innovative solutions in order to achieve a better design of services and interventions throughout the entire chain of care, including public health and prevention. It implies, among others, strategies for strengthening community care and primary care in relation to social care and prevention, redesigning hospital care and de-institutionalising long term care with more care provided closer to home. This implies placing more emphasis on self-management of patients and new ways of linking health and social care. There are many opportunities to learn from one another on what works best under what conditions, agreeing on what issues could be best researched jointly, and where the problems are more localized. This is an opportunity of capitalizing on existing know-how and to draw on comparative advantages in European research, thus enhancing innovation.
¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Personnel costs.
Los costes de personal subvencionables cubren las horas de trabajo efectivo de las personas directamente dedicadas a la ejecución de la acción. Los propietarios de pequeñas y medianas empresas que no perciban salario y otras personas físicas que no perciban salario podrán imputar los costes de personal sobre la base de una escala de costes unitarios
Purchase costs.
Los otros costes directos se dividen en los siguientes apartados: Viajes, amortizaciones, equipamiento y otros bienes y servicios. Se financia la amortización de equipos, permitiendo incluir la amortización de equipos adquiridos antes del proyecto si se registra durante su ejecución. En el apartado de otros bienes y servicios se incluyen los diferentes bienes y servicios comprados por los beneficiarios a proveedores externos para poder llevar a cabo sus tareas
Subcontracting costs.
La subcontratación en ayudas europeas no debe tratarse del core de actividades de I+D del proyecto. El contratista debe ser seleccionado por el beneficiario de acuerdo con el principio de mejor relación calidad-precio bajo las condiciones de transparencia e igualdad (en ningún caso consistirá en solicitar menos de 3 ofertas). En el caso de entidades públicas, para la subcontratación se deberán de seguir las leyes que rijan en el país al que pertenezca el contratante
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 5:. Los elementos básicos de la innovación son integrados de manera que la configuración final es similar a su aplicación final, es decir que está listo para ser usado en la simulación de un entorno real. Se mejoran los modelos tanto técnicos como económicos del diseño inicial, se ha identificado adicionalmente aspectos de seguridad, limitaciones ambiéntales y/o regulatorios entre otros. + info.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
Please read carefully all provisions below before the preparation of your application.
 
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects (follow the links to China, Japan, Republic of Korea, Mexico, Russia, Taiwan, USA).
 
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme.
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
 
Evaluation
3.1  Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme.
3.2 Submission and evaluation process: Guide to the submission and evaluation process
      
Indicative timetable for evaluation and grant agreement:
Information on the outcome of single-stage evaluation: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
 
Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
Coord...
Please read carefully all provisions below before the preparation of your application.
 
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects (follow the links to China, Japan, Republic of Korea, Mexico, Russia, Taiwan, USA).
 
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme.
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
 
Evaluation
3.1  Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme.
3.2 Submission and evaluation process: Guide to the submission and evaluation process
      
Indicative timetable for evaluation and grant agreement:
Information on the outcome of single-stage evaluation: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
 
Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
Coordination and Support Action:
Specific provisions and funding rates
Standard proposal template
Standard evaluation form
H2020 General MGA -Multi-Beneficiary
Annotated Grant Agreement
 
Additional provisions:
Horizon 2020 budget flexibility
Classified information
 
Open access must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged. Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
 
Additional documents:
H2020 Work Programme 2016-17: Health, demographic change and wellbeing
H2020 Work Programme 2016-17: Dissemination, Exploitation and Evaluation
H2020 Work Programme 2016-17: General Annexes
Legal basis: Horizon 2020 - Regulation of Establishment
Legal basis: Horizon 2020 Rules for Participation
Legal basis: Horizon 2020 Specific Programme
 
Garantías:
No exige Garantías
No existen condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda tiene efecto incentivador, por lo que el proyecto no puede haberse iniciado antes de la presentación de la solicitud de ayuda. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.
H2020-SC1-2016-2017 Towards an ERA-NET for building sustainable and resilient health system models Specific Challenge:Currently, public health-related research, whether population health or health services research, is fragmented, not coor...
Sin info.
SC1-HCO-01-2018-2019-2020 Actions in support of the International Consortium for Personalised Medicine
en consorcio:
Cerrada hace 5 años | Próxima convocatoria prevista para el mes de
SC1-HCO-03-2020 Bridging the divide in health research and innovation – boosting return on investment
en consorcio: Specific Challenge:The Innovation Union Scoreboard reveals significant disparities in terms of research and innovation performance among the...
Cerrada hace 5 años | Próxima convocatoria prevista para el mes de
SC1-HCO-17-2020 Coordinating and supporting research on the human microbiome in Europe and beyond
en consorcio: Specific Challenge:Integration and application of metagenomics data from the human microbiome has shown large potential for personalised med...
Cerrada hace 5 años | Próxima convocatoria prevista para el mes de
SC1-HCO-07-2020 ERA-NET to support the Joint Programming Initiative on Antimicrobial resistance (JPIAMR)
en consorcio: Specific Challenge:Antimicrobial resistance (AMR) is a serious challenge that has reached alarming levels in the EU and globally. There is a...
Cerrada hace 5 años | Próxima convocatoria prevista para el mes de
SC1-HCO-19-2020 Reliable and accessible information on cell and gene-based therapies
en consorcio: Specific Challenge:Cell and gene-based therapies have the potential to treat many debilitating diseases and conditions. However, the pace of...
Cerrada hace 5 años | Próxima convocatoria prevista para el mes de